Mirati Therapeutics, Inc.·4

Jan 24, 4:00 PM ET

CARTER BRUCE L A 4

4 · Mirati Therapeutics, Inc. · Filed Jan 24, 2023

Insider Transaction Report

Form 4
Period: 2023-01-20
Transactions
  • Award

    Non Qualified Stock Option (right to buy)

    2023-01-20+7,5207,520 total
    Exercise: $45.66Exp: 2033-01-20Common Stock (7,520 underlying)
  • Award

    Common Stock

    2023-01-20+4,44410,465 total
Footnotes (2)
  • [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
  • [F2]The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.

Documents

2 files
  • 4
    marketforms-58264.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POA DOCUMENT